{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Glaxo Group Limited", "item": "https://www.patentleaderboard.com/2021/company/glaxo-group-limited"}, {"@type": "ListItem", "position": 4, "name": "Patrick Wire", "item": "https://www.patentleaderboard.com/2021/inventor/fl:pa_ln:wire-1"}]}

Home › 2021 › Glaxo Group Limited › Patrick Wire

Patrick Wire — 1 Patent in 2021

GLGlaxo Group Limited: 1 patents #4 of 19Top 25%

Durham, NC: #207 of 654 inventorsTop 35%

North Carolina: #1,964 of 5,924 inventorsTop 35%

Overall (2021): #305,841 of 548,734Top 60%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
11090294	Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist	Darrell Baker, Mark Bruce, Glenn D. Crater, Brian Noga, Marian Thomas	2021-08-17

Patrick Wire — 1 Patent in 2021

Issued Patents 2021

Patent Widget